← All organizations

Genfit

For profitWebsite ↗

Also known as: Chief Medical Officer, Genfit | Development Director Genfit, France | Genfit | Genfit, France | GENFIT, France

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 26, 2025

Timeline

1990s

Jun 1, 1999
Genfit— Founded

2020s

Sep 19, 2023
Versantis— Acquired
Sep 20, 2023
Versantis AG— Acquired

Drugs by trial phase (7 distinct, 23 trials)

Phase 3 (1 own, 0 via acquisition)

elafibranor

Phase 2 (2 own, 1 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (41)

NCT07110441Lead sponsorPhase 1Aug 26, 2025
NCT05874414Study directorPhase 1/Phase 2Jun 30, 2023
NCT05874414Lead sponsorPhase 1/Phase 2Jun 30, 2023
NCT05368935Lead sponsorPhase 1Apr 25, 2022
NCT05368935Study directorPhase 1Apr 25, 2022
NCT05116826Lead sponsorPhase 1Nov 5, 2021
NCT05116826Study directorPhase 1Nov 5, 2021
NCT04526665Lead sponsorPhase 3Sep 24, 2020
NCT04526665Study directorPhase 3Sep 24, 2020
NCT04171752Study directorPhase 1Nov 22, 2019
NCT04171752Lead sponsorPhase 1Nov 22, 2019
NCT03953456Lead sponsorPhase 2Aug 31, 2019
NCT03953456Study directorPhase 2Aug 31, 2019
NCT03985969Study directorPhase 1Jun 30, 2019
NCT03985969Lead sponsorPhase 1Jun 30, 2019

Details

Founded: Loos, FR Jun 1, 1999
Last known activity: Aug 26, 2025